CrookD.Will the route of administration influence the potential cardiovascular benefits of postmenopausal HRT?J Br Meno Soc1999; 5: 35–39.
2.
GrodsteinFStampferMJ. The cardioprotective effect of estrogens. In: StuddJWW (ed). The Management of the Menopause Annual Review. Carnforth: Parthenon Publishing, 1998, 211–19.
3.
GrodsteinFStampferMJMansonJE. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl J Med1996; 335: 453–461.
4.
HulleySGradyDBushT. Randomised trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women (HERS). JAMA1998; 280: 605–613.
5.
NewtonJ N. The epidemiology of coronary heart disease and HRT. What are the contentious issues?J Br Meno Soc1998; 4: 135–142.
6.
WhiteheadMIStampferMH. HERS - a missed opportunity (editorial). Climacteric1998; 1: 170–171.